Sort
30,917 grants matching “tumor microenvironment”
Mechanisms of breast cancer associated with obesity
$644,288Charlotte Kuperwasser · Tufts University Boston · R01 · FY2012 · CA
Validation of a novel 3D culture platform for TNBC treatment selection
$644,226Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2022 · CA
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
$644,191Jenny C-N Chang · Methodist Hospital Research Institute · R01 · FY2023 · CA
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
$644,078Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Expanding the therapeutic window of chemoradiation through radiation-responsive nanoparticle drug depots
$644,034Miles A Miller · Massachusetts General Hospital · R01 · FY2025 · CA
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer
$643,839Andrew T Chan · Massachusetts General Hospital · R01 · FY2020 · CA
Structure-based inhibition of chemokine signaling in the inflamed pancreas
$643,818Brian F Volkman · Medical College Of Wisconsin · R01 · FY2025 · DK
Phase 1 First in Human Trial to Assess Safety and Tolerability of the Novel ACK1 Inhibitor (R)-9b in Patients with Prostate Cancer
$643,764Nupam P Mahajan · Washington University · R01 · FY2025 · CA
Translation of a novel combination therapy approach for non-Hodgkin lymphoma
$643,654Shruthi Naik · Mayo Clinic Rochester · U01 · FY2024 · CA
Contemporary Approaches to Cancer Cell Signaling and Communication
$643,653Jing Yang · University Of California, San Diego · T32 · FY2022 · CA
Mechanisms of impaired T-cell mechanosensing of melanoma antigens
$643,620Cheng Zhu · Georgia Institute Of Technology · U01 · FY2021 · CA
MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
$643,560Max Wintermark · Stanford University · R01 · FY2018 · CA
Development of a New Multiplexed Imaging Strategy for Immunoprofiling using Raman-Active Nanoparticles
$643,522Cristina L. Zavaleta · University Of Southern California · R01 · FY2024 · CA
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
$643,177Charles S Cobbs · Swedish Medical Center, First Hill · R01 · FY2014 · CA
Exploiting A Critical Vulnerability To Glutamine Antimetabolite Therapy in Fibrolamellar Hepatocellular Carcinoma (FLC)
$643,101Mark Yarchoan · Johns Hopkins University · R01 · FY2025 · CA
Patient-specific, high-sensitivity spectral CT for assessment of pancreatic cancer
$643,028Peter B Noãl · University Of Pennsylvania · R01 · FY2021 · EB
The effects of PD-1 on tumor-mediated âemergencyâ myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
$642,962Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Design and characterization of bacterial population dynamics in solid tumor models
$642,937Jeff M Hasty · University Of California, San Diego · R01 · FY2021 · EB
The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis
$642,928William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment
$642,911Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment
$642,911Hossein Khiabanian · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment
$642,911Hossein Khiabanian · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment
$642,910Hossein Khiabanian · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model
$642,825Ryan C Fields · Washington University · R01 · FY2017 · CA
Immune Responses in Otitis Prone Children
$642,800Michael E Pichichero · Rochester General Hospital (Ny) · R01 · FY2015 · DC